ストックスクリーナーアプリを入手
0.00
100.00%
-15.68
Reshape Lifesciences Inc (RSLS) 最新ニュース
Will ReShape Lifesciences Inc. outperform tech stocksJuly 2025 Outlook & Reliable Breakout Stock Forecasts - classian.co.kr
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update - MarketScreener
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why - MSN
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - MarketScreener
Recovery Setup Building in ReShape Lifesciences Inc. Experts SayLong Term Investment Summary Analysis - beatles.ru
How to manage a losing position in ReShape Lifesciences Inc.2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Heatmap analysis for ReShape Lifesciences Inc. and competitorsWeekly Gains Summary & Long-Term Capital Growth Ideas - Newser
ReShape Lifesciences Inc. stock prediction for this weekJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - Newser
Real time social sentiment graph for ReShape Lifesciences Inc.Weekly Profit Recap & Free Safe Entry Trade Signal Reports - Newser
ReShape Lifesciences Inc. stock chart pattern explainedWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - Newser
Will ReShape Lifesciences Inc. rebound enough to break evenJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - Newser
Real time pattern detection on ReShape Lifesciences Inc. stockWeekly Profit Summary & Low Risk High Win Rate Picks - Newser
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND - MarketScreener
Vyome Holdings, Inc. shares fall 15.75% premarket after completing merger with ReShape Lifesciences. - AInvest
Vyome Therapeutics Completes Merger with ReShape Lifesciences; Nasdaq Debut Under Ticker HIND - Sahyadri Startups
Vyome Holdings, Inc. shares fall 8.93% premarket after closing merger transaction with ReShape Lifesciences Inc. - AInvest
Vyome Therapeutics' Strategic Merger with ReShape Lifesciences: A Launchpad for US-India Biotech Synergy - AInvest
Chart overlay techniques for tracking ReShape Lifesciences Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - Newser
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionTrade Exit Summary & Low Risk Profit Maximizing Plans - Newser
Vyome Therapeutics Completes Merger with ReShape Lifesciences - AInvest
Vyome Therapeutics Completes Merger With ReShape Lifesciences - MarketScreener
Reshape Lifesciences Reports Q2 2025 Financial Results - TipRanks
Vyome Completes Merger with ReShape Lifesciences, Set to Trade on Nasdaq as HIND - AInvest
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow - The Globe and Mail
ReShape Lifesciences Inc. SEC 10-Q Report - TradingView
ReShape Lifesciences (RSLS.O) Surges 28.4%: Is It a Short Squeeze or a New Narrative? - AInvest
ReShape Lifesciences Skyrockets 25.47%—What’s Fueling This Pre-Market Surge? - AInvest
Vyome To Begin Trading On Nasdaq Via Reverse Merger With ReShape Lifesciences Tomorrow - Nasdaq
Riding the Waves: A Guide to Investing in RSLS Stock - investchronicle.com
ReShape Lifesciences Surges 31% on Nasdaq Merger Approval: A New Era for Vyome Holdings? - AInvest
Why Did ReShape Lifesciences Plunge 8.75% Amid Vyome Merger? - AInvest
ReShape Lifesciences Stock Scheduled to Reverse Split on Monday, August 18th (NASDAQ:RSLS) - Defense World
ReShape Lifesciences Approves Asset Sale and Merger - TipRanks
Vyome Therapeutics Inc. completed the acquisition of ReShape Lifesciences Inc. in a reverse merger transaction. - MarketScreener
Health Care Stocks Climb As Deals And Results Grab Attention - Finimize
ReShape Lifesciences Soars 66.99% on Nasdaq Merger Approval: A Biotech Merger Sparking Market Frenzy - AInvest
ReShape Lifesciences' Merger With Vyome Therapeutics Receives Nasdaq Approval for Listing - MarketScreener
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why By Stocktwits - Investing.com India
Vyome announces Nasdaq approval of merger with ReShape Lifesciences - TipRanks
Vyome Therapeutics Announces Nasdaq Approval for Merger with ReShape Lifesciences - AInvest
ReShape Lifesciences Stock Rocketed 61% Today – Here’s Why - Stocktwits
Reshape Lifesciences Stock Rocketed 37% Today Here's Why - Menafn
CapsoVision (NASDAQ:CV) versus ReShape Lifesciences (OTCMKTS:RSLSD) Head to Head Comparison - Defense World
Reviewing ReShape Lifesciences (OTCMKTS:RSLSD) and CapsoVision (NASDAQ:CV) - Defense World
Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND - 富途牛牛
Vyome Announces New Board of Directors with Deep MIT and AI Ties - The Globe and Mail
How ReShape Lifesciences Inc. stock performs during market volatilityFree Portfolio Optimization Guide - newsyoung.net
ReShape Lifesciences shareholders approve merger with Vyome Therapeutics - MSN
ReShape Lifesciences Approves Asset Sale and Merger with Vyome Therapeutics - AInvest
ReShape Lifesciences RSLS 2025Q2 Earnings Preview Upside Potential on Strategic Reshape Initiatives - AInvest
ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Ticker Symbol to Change to HIND - AInvest
ReShape announces shareholder approval of Vyome merger - TipRanks
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - MarketScreener
Should you hold or exit ReShape Lifesciences Inc. nowSector-Wise Equity Performance Trend Forecast - Newser
How does ReShape Lifesciences Inc. generate profit in a changing economyAccess high-quality stock research instantly - Jammu Links News
What are the latest earnings results for ReShape Lifesciences Inc.Navigate the market with precision tools - Jammu Links News
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsRapid-fire capital growth - Jammu Links News
Is it the right time to buy ReShape Lifesciences Inc. stockGet real-time alerts on top-performing stocks - Jammu Links News
How strong is ReShape Lifesciences Inc. company’s balance sheetExceptional trading results - Jammu Links News
Is ReShape Lifesciences Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
What is the dividend policy of ReShape Lifesciences Inc. stockUnlock expert trading strategies for growth - Jammu Links News
What are the technical indicators suggesting about ReShape Lifesciences Inc.Accelerated profit realization - Jammu Links News
What are ReShape Lifesciences Inc. company’s key revenue driversSpectacular growth rates - Jammu Links News
0.56%
0.41%
大文字化:
|
ボリューム (24 時間):